Traders emerging from one of the most turbulent weeks in history will likely need to brace for more volatility as the Street gears up for jobs data.» Read More
Sanofi CEO Christopher Viehbacher discusses his company's $20 billion acquisition of Genzyme and other opportunities he sees in the pharmaceutical market.
May has historically been a bad month for stocks, so should investors "sell in May and go away?" Barbara Reinhard, Credit Suisse chief investment strategist, weighs in.
If you have high hopes for the upcoming China GDP report, this strategist has a trade for you.
Warmer winter days boosted economic activity, but that is so last month.
The S&P Biotech Index is up more than 10 percent and Celgene is one of its biggest gainers. Robert Hugin, Celgene chairman & CEO, discusses what's driving the company's growth, including its recent acquisition of Avila Therapeutics.
Trading volume should power JPMorgan Chase to report a very good quarter, while refinancing will boost Wells Fargo earnings, Stifel Nicolaus analyst Christopher Mutascio told CNBC Thursday.
It’s way too early to determine which CEOs will make Herb's annual Worst CEO list, but with three from last year’s list already kicked out of their jobs, the hunt is on.
Sometimes it takes an activist investor slate of directors to engineer a rebound in a technology firm potentially headed the way of the dinosaur. That may not be the case at floundering solar company First Solar though.
Central banks around the world are battling domestic debt with monetary easing, effectively low borrowing rates, as their tool of choice. This has Pimco’s Neel Kashkari bullish on global equities.
Can the average stock market investor make money investing in Wall Street's exclusive private-equity and debt trading clubs?
CNBC's Brian Shactman explains why investors are attracted to high dividend yielding tobacco stocks.
Global stocks are entering a potentially negative period, according to one index with a solid track record that is indicating there is more than European debt weighing on investors’ minds.
Will J.P. Morgan and Wells Fargo raise the earnings bar too high for the other banks? Christopher Mutascio, Stifel Nicolaus managing director and Paul Miller, FBR Capital Markets managing director, discuss the outlook on bank earnings, which begins on Friday.
Stocks are rallying for a second day on hopes that China is headed for a soft landing. David Kelly, J.P. Morgan Funds chief market strategist, offers advice for investing in a slow-growth economy.
CNBC's Jon Fortt reports on Sony's reorganization plans.
The Fast Money Halftime crew checks out what's trending on Twitter now.
How to trade China's GDP number, with Andy Busch, BMO Capital Markets. Credit Suisse increased its price target for Apple from $700 to $750 and Qualcomm from $70 to $80, with Kulbinder Garcha, Credit Suisse managing director.
While natural gas and coal names hover around market lows, is there a derivative buying opportunity? Dan Dicker, Merc Bloc president, offers insight.
Coal stocks are feeling pressure as power stations switch to cheaper natural gas. David Lipschitz, Metals & Mining analyst, weighs in on whether the worst could be over for coal stocks.
Google announces its Q1 earnings report tonight and many investors are hoping the company will rebound from last quarter's huge miss. Ken Sena, Evercore Partners analyst, weighs in.